Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial

OBJECTIVE: To evaluate the efficacy and safety of dasiglucagon, a ready-to-use, next-generation glucagon analog in aqueous formulation for subcutaneous dosing, for treatment of severe hypoglycemia in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: This randomized, double-blind trial includ...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Care
Main Authors: Pieber, Thomas R., Aronson, Ronnie, Hövelmann, Ulrike, Willard, Julie, Plum-Mörschel, Leona, Knudsen, Kim M., Bandak, Benedikte, Tehranchi, Ramin
Format: Artigo
Language:Inglês
Published: American Diabetes Association 2021
Subjects:
Emerging Therapies: Drugs and Regimens
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247529/
https://ncbi.nlm.nih.gov/pubmed/35239971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-2995
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items